83 related articles for article (PubMed ID: 9708515)
1. Carbon-11-methionine uptake in squamous cell head and neck cancer.
Lindholm P; Leskinen S; Lapela M
J Nucl Med; 1998 Aug; 39(8):1393-7. PubMed ID: 9708515
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine.
Lindholm P; Leskinen-Kallio S; Grénman R; Lehikoinen P; Någren K; Teräs M; Ruotsalainen U; Joensuu H
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):787-94. PubMed ID: 7790265
[TBL] [Abstract][Full Text] [Related]
3. Carbon-11-methionine and PET is an effective method to image head and neck cancer.
Leskinen-Kallio S; Någren K; Lehikoinen P; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1992 May; 33(5):691-5. PubMed ID: 1569477
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.
Nuutinen J; Jyrkkiö S; Lehikoinen P; Lindholm P; Minn H
Radiother Oncol; 1999 Sep; 52(3):225-32. PubMed ID: 10580868
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
6. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
[TBL] [Abstract][Full Text] [Related]
7. Head and neck cancer: effect of food ingestion on uptake of C-11 methionine.
Lindholm P; Leskinen-Kallio S; Kirvelä O; Någren K; Lehikoinen P; Pulkki K; Peltola O; Ruotsalainen U; Teräs M; Joensuu H
Radiology; 1994 Mar; 190(3):863-7. PubMed ID: 8115641
[TBL] [Abstract][Full Text] [Related]
8. Imaging of head and neck tumors with positron emission tomography and [11C]methionine.
Leskinen-Kallio S; Lindholm P; Lapela M; Joensuu H; Nordman E
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1195-9. PubMed ID: 7961029
[TBL] [Abstract][Full Text] [Related]
9. L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate.
de Boer JR; Pruim J; van der Laan BF; Que TH; Willemsen AT; Albers FW; Vaalburg W
J Nucl Med; 2003 Mar; 44(3):341-6. PubMed ID: 12620998
[TBL] [Abstract][Full Text] [Related]
10. Imaging of uterine carcinoma by carbon-11-methionine and PET.
Lapela M; Leskinen-Kallio S; Varpula M; Grenman S; Alanen K; Någren K; Lehikoinen P; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1994 Oct; 35(10):1618-23. PubMed ID: 7931659
[TBL] [Abstract][Full Text] [Related]
11. [11C]methionine quantitation in cancer PET studies.
Leskinen-Kallio S; Huovinen R; Någren K; Lehikoinen P; Ruotsalainen U; Teräs M; Joensuu H
J Comput Assist Tomogr; 1992; 16(3):468-74. PubMed ID: 1592933
[TBL] [Abstract][Full Text] [Related]
12. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
[TBL] [Abstract][Full Text] [Related]
13. Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.
Sutinen E; Jyrkkiö S; Alanen K; Någren K; Minn H
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):72-7. PubMed ID: 12483412
[TBL] [Abstract][Full Text] [Related]
14. Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma.
de Boer JR; Pruim J; Albers FW; Burlage F; Vaalburg W; van der Laan BF
J Nucl Med; 2004 Dec; 45(12):2052-7. PubMed ID: 15585481
[TBL] [Abstract][Full Text] [Related]
15. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Minn H; Clavo AC; Grénman R; Wahl RL
J Nucl Med; 1995 Feb; 36(2):252-8. PubMed ID: 7830126
[TBL] [Abstract][Full Text] [Related]
16. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography.
Fujiwara T; Matsuzawa T; Kubota K; Abe Y; Itoh M; Fukuda H; Hatazawa J; Yoshioka S; Yamaguchi K; Ito K
J Nucl Med; 1989 Jan; 30(1):33-7. PubMed ID: 2536082
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
[TBL] [Abstract][Full Text] [Related]
18. Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma.
Zhang B; Li X; Lu X
Acta Otolaryngol; 2010 Jul; 130(7):756-62. PubMed ID: 20085442
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.
Cicone F; Loose D; Deron P; Vermeersch H; Signore A; Van de Vyvere F; Scopinaro F; Van de Wiele C
Nucl Med Commun; 2008 May; 29(5):431-5. PubMed ID: 18391726
[TBL] [Abstract][Full Text] [Related]
20. The role of positron emission tomography in occult primary head and neck cancers.
Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
